This trial studies financial difficulty in participants with chronic lymphocytic leukemia and multiple myeloma. Assessment of financial difficulty may help to better understand the financial impact of cancer and come up with ways to help participants avoid financial problems during treatment.

SparkCures ID	1030
Enrollment	500 Patients
Trial Sponsors	Alliance for Clinical Trials in Oncology
Trial Collaborators	National Cancer Institute (NCI) Leukemia and Lymphoma Society
NCT Identifier	NCT03870633

Am I Eligible?

The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.

The following criteria is provided for health care professionals.

Inclusion Criteria:

PATIENT ELIGIBILITY CRITERIA

Patients must have current diagnosis of chronic lymphocytic leukemia (CLL) or multiple myeloma (MM)
Patients' medical records must be available to the registering institution
Eligible patients must have been prescribed drug-based anticancer therapy, whether administered orally or by infusion, within the prior 12 months. Specifically, eligible patients are those who:
- Are presently being treated with infused or orally-administered anticancer therapy, OR
- Completed infused or orally-administered anti-cancer therapy in the past 12 months, OR
- Were prescribed infused or orally-administered anticancer therapy within the prior 12 months yet chose to forego treatment
Not currently enrolled in a clinical trial in which drug is supplied by the study
Patients with psychiatric illness or other mental impairment that would preclude their ability to give informed consent or to respond to the telephone survey are not eligible
Patients must be able to read and comprehend English or Spanish

Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma

Overview

Am I Eligible?

US Trial Locations